← Back to Screener
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Price$51.52
Value ScoreB
Growth ScoreC
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-0.38%
Price vs S&P 500 (4W)5.16%
VGM Score57.90
Market Capitalization$102.10B
P/E Ratio (Annual)13.34x
Indicated Dividend Yield (Annual)3.68%
All Metrics
P/CF (Annual)9.85x
Book Value / Share (Quarterly)$5.89
P/TBV (Annual)325.88x
Indicated Dividend (Annual)$89.68
Revenue Growth (3Y)3.66%
Cash Flow / Share (Quarterly)$1.57
Payout Ratio (TTM)44.52%
Price vs S&P 500 (YTD)-1.94%
Gross Margin (TTM)72.94%
Net Profit Margin (TTM)17.78%
EPS (TTM)$1.91
10-Day Avg Trading Volume5.53M
EPS Excl Extra (TTM)$1.91
Revenue Growth (5Y)6.05%
EPS (Annual)$1.86
Dividend / Share (Annual)$0.83
ROI (Annual)16.76%
Gross Margin (Annual)73.05%
Net Profit Margin (5Y Avg)22.14%
Cash / Share (Quarterly)$1.14
P/E Basic Excl Extra (TTM)13.09x
Revenue Growth QoQ (YoY)1.50%
EPS Growth (5Y)-0.54%
P/E Normalized (Annual)13.34x
ROA (Last FY)9.35%
Revenue Growth TTM (YoY)3.97%
EBITD / Share (TTM)$2.65
ROE (5Y Avg)52.18%
Operating Margin (TTM)24.43%
Cash Flow / Share (Annual)$1.56
P/B Ratio4.27x
P/B Ratio (Quarterly)4.69x
Net Income / Employee (Annual)$114,445
EV / Revenue (TTM)2.80x
Net Interest Coverage (TTM)11.98x
ROA (TTM)9.53%
EPS Growth QoQ (YoY)8.61%
EV / EBITDA (TTM)11.35x
EPS Incl Extra (Annual)$1.86
Current Ratio (Annual)0.82x
Quick Ratio (Quarterly)0.52x
3-Month Avg Trading Volume5.62M
52-Week Price Return28.43%
EV / Free Cash Flow (Annual)19.32x
P/E Incl Extra (TTM)13.09x
Revenue / Employee (TTM)$656,418
Tangible BV / Share (Quarterly)$2.06
P/S Ratio (Annual)2.33x
Asset Turnover (Annual)0.53x
52-Week High$2282.00
Operating Margin (5Y Avg)19.76%
EPS Excl Extra (Annual)$1.86
CapEx CAGR (5Y)5.92%
Tangible BV CAGR (5Y)-48.07%
26-Week Price Return7.55%
Quick Ratio (Annual)0.52x
13-Week Price Return-8.67%
Total Debt / Equity (Annual)1.08x
Current Ratio (Quarterly)0.79x
Enterprise Value$123.00B
Revenue / Share Growth (5Y)5.60%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)2.08%
Revenue / Employee (Annual)$654,142
Inventory Turnover (Annual)1.52x
Pretax Margin (Annual)22.66%
Cash / Share (Annual)$1.04
3-Month Return Std Dev25.18%
Gross Margin (5Y Avg)71.26%
Net Income / Employee (TTM)$116,720
EBITDA CAGR (5Y)5.78%
EBITDA Interim CAGR (5Y)6.16%
ROE (Last FY)34.90%
Net Interest Coverage (Annual)7.86x
EPS Basic Excl Extra (Annual)$1.86
P/FCF (TTM)16.04x
Receivables Turnover (TTM)4.43x
EV / Free Cash Flow (TTM)19.32x
Total Debt / Equity (Quarterly)1.07x
EPS Incl Extra (TTM)$1.91
Receivables Turnover (Annual)5.68x
ROI (TTM)17.01%
Dividend Growth Rate (5Y)-8.93%
P/S Ratio (TTM)2.33x
Pretax Margin (5Y Avg)17.50%
Revenue / Share (Annual)$10.62
Tangible BV / Share (Annual)$0.06
Forward P/E10.08x
Free OCF CAGR (5Y)-5.17%
Price vs S&P 500 (52W)4.06%
P/E Ratio (TTM)13.09x
EPS Growth TTM (YoY)86.73%
Year-to-Date Return6.22%
5-Day Price Return5.18%
EPS Normalized (Annual)$1.86
ROA (5Y Avg)10.49%
Net Profit Margin (Annual)17.50%
Month-to-Date Return3.00%
Cash Flow / Share (TTM)$2.69
EBITD / Share (Annual)$2.61
EPS Growth (3Y)-27.62%
Operating Margin (Annual)24.28%
LT Debt / Equity (Annual)0.86x
P/CF (TTM)9.86x
ROI (5Y Avg)19.88%
P/E Excl Extra (TTM)13.09x
LT Debt / Equity (Quarterly)0.78x
EPS Basic Excl Extra (TTM)$1.91
P/TBV (Quarterly)17.94x
Payout Ratio (Annual)44.86%
P/B Ratio (Annual)4.51x
Dividend / Share (TTM)$0.85
Inventory Turnover (TTM)1.46x
Pretax Margin (TTM)22.69%
Book Value / Share (Annual)$5.38
Price vs S&P 500 (13W)-16.93%
Net Margin Growth (5Y)-5.81%
Dividend Yield (TTM)3.40%
Beta1.24x
P/FCF (Annual)16.04x
Revenue / Share (TTM)$10.77
ROE (TTM)35.78%
52-Week Low$1315.00
vGradeB
gGradeC
mGradeB
vgmGradeC
Show chart for
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.44
3.44
3.44
3.50
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | B | C | B | $51.52 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
A leading global pharmaceutical company with a diversified therapeutic portfolio spanning respiratory, vaccines, antivirals, and specialty care. The company is expanding its presence in high-growth areas including oncology and immunology. Strategic partnerships and joint ventures, particularly in HIV treatment, strengthen its market position across key segments.